Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Germ-line and somatic presentations of the EGFR T790M mutation in lung cancer.

Literature DB >> 19096324

Germ-line and somatic presentations of the EGFR T790M mutation in lung cancer.

Ludmila Prudkin, Ximing Tang, Ignacio I Wistuba.

Abstract

Entities: Chemical Disease Gene Mutation Species

Mesh：

Substances：

Year: 2009 PMID： 19096324 PMCID： PMC4512946 DOI： 10.1097/JTO.0b013e3181915f92

Source DB: PubMed Journal: J Thorac Oncol ISSN： 1556-0864 Impact factor: 15.609

× No keyword cloud information.

7 in total

1. Inherited susceptibility to lung cancer may be associated with the T790M drug resistance mutation in EGFR.

Authors: Daphne W Bell; Ira Gore; Ross A Okimoto; Nadia Godin-Heymann; Raffaella Sordella; Roseann Mulloy; Sreenath V Sharma; Brian W Brannigan; Gayatry Mohapatra; Jeff Settleman; Daniel A Haber
Journal: Nat Genet Date: 2005-10-30 Impact factor: 38.330

2. EGFR mutation and resistance of non-small-cell lung cancer to gefitinib.

Authors: Susumu Kobayashi; Titus J Boggon; Tajhal Dayaram; Pasi A Jänne; Olivier Kocher; Matthew Meyerson; Bruce E Johnson; Michael J Eck; Daniel G Tenen; Balázs Halmos
Journal: N Engl J Med Date: 2005-02-24 Impact factor: 91.245

3. Presence of epidermal growth factor receptor gene T790M mutation as a minor clone in non-small cell lung cancer.

Authors: Michio Inukai; Shinichi Toyooka; Sachio Ito; Hiroaki Asano; Shuji Ichihara; Junichi Soh; Hiroshi Suehisa; Mamoru Ouchida; Keisuke Aoe; Motoi Aoe; Katsuyuki Kiura; Nobuyoshi Shimizu; Hiroshi Date
Journal: Cancer Res Date: 2006-08-15 Impact factor: 12.701

4. EGFR tyrosine kinase domain mutations are detected in histologically normal respiratory epithelium in lung cancer patients.

Authors: Ximing Tang; Hisayuki Shigematsu; B Nebiyou Bekele; Jack A Roth; John D Minna; Waun Ki Hong; Adi F Gazdar; Ignacio I Wistuba
Journal: Cancer Res Date: 2005-09-01 Impact factor: 12.701

5. Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers.

Authors: Hisayuki Shigematsu; Li Lin; Takao Takahashi; Masaharu Nomura; Makoto Suzuki; Ignacio I Wistuba; Kwun M Fong; Huei Lee; Shinichi Toyooka; Nobuyoshi Shimizu; Takehiko Fujisawa; Ziding Feng; Jack A Roth; Joachim Herz; John D Minna; Adi F Gazdar
Journal: J Natl Cancer Inst Date: 2005-03-02 Impact factor: 13.506

6. EGFR-T790M is a rare lung cancer susceptibility allele with enhanced kinase activity.

Authors: Haris Vikis; Mitsuo Sato; Michael James; Daolong Wang; Yian Wang; Min Wang; Dongmei Jia; Yan Liu; Joan E Bailey-Wilson; Christopher I Amos; Susan M Pinney; Gloria M Petersen; Mariza de Andrade; Ping Yang; Jonathan S Wiest; Pamela R Fain; Ann G Schwartz; Adi Gazdar; Colette Gaba; Henry Rothschild; Diptasri Mandal; Elena Kupert; Daniela Seminara; Avinash Viswanathan; Ramaswamy Govindan; John Minna; Marshall W Anderson; Ming You
Journal: Cancer Res Date: 2007-05-15 Impact factor: 12.701

7. Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain.

Authors: William Pao; Vincent A Miller; Katerina A Politi; Gregory J Riely; Romel Somwar; Maureen F Zakowski; Mark G Kris; Harold Varmus
Journal: PLoS Med Date: 2005-02-22 Impact factor: 11.069

7 in total

19 in total

1. Hereditary lung cancer syndrome targets never smokers with germline EGFR gene T790M mutations.

Authors: Adi Gazdar; Linda Robinson; Dwight Oliver; Chao Xing; William D Travis; Junichi Soh; Shinichi Toyooka; Lori Watumull; Yang Xie; Kemp Kernstine; Joan H Schiller
Journal: J Thorac Oncol Date: 2014-04 Impact factor: 15.609

2. Concurrent molecular alterations in tumors with germ line epidermal growth factor receptor T790M mutations.

Authors: Anish Thomas; Liqiang Xi; Corey A Carter; Arun Rajan; Sean Khozin; Eva Szabo; Phillip A Dennis; Giuseppe Giaccone; Mark Raffeld
Journal: Clin Lung Cancer Date: 2013-03-26 Impact factor: 4.785

Review 3. Rational, biologically based treatment of EGFR-mutant non-small-cell lung cancer.

Authors: William Pao; Juliann Chmielecki
Journal: Nat Rev Cancer Date: 2010-10-22 Impact factor: 60.716

4. Drug resistance and its significance for treatment decisions in non-small-cell lung cancer.

Authors: E Tsvetkova; G D Goss
Journal: Curr Oncol Date: 2012-06 Impact factor: 3.677

Review 5. Mechanisms of resistance to EGFR targeted therapies.

Authors: Gorjan Hrustanovic; Bianca J Lee; Trever G Bivona
Journal: Cancer Biol Ther Date: 2013-01-28 Impact factor: 4.742

6. Analysis of genetic variants in never-smokers with lung cancer facilitated by an Internet-based blood collection protocol: a preliminary report.

Authors: Nicolas Girard; Emil Lou; Christopher G Azzoli; Rekha Reddy; Mark Robson; Megan Harlan; Irene Orlow; Yasushi Yatabe; Khedoudja Nafa; Marc Ladanyi; Agnes Viale; Mark G Kris; Gregory Riely; Vincent Miller; Robert J Klein; Keitaro Matsuo; William Pao
Journal: Clin Cancer Res Date: 2010-01-12 Impact factor: 12.531

10. Mechanisms of Resistance to Epidermal Growth Factor Receptor Inhibitors and Novel Therapeutic Strategies to Overcome Resistance in NSCLC Patients.

Authors: Luping Lin; Trever G Bivona
Journal: Chemother Res Pract Date: 2012-08-29